• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Imatinib induced Stevens-Johnson syndrome: lack of recurrence following re-challenge with a lower dose.

作者信息

Pavithran Keechilat, Thomas Mathew

出版信息

Indian J Dermatol Venereol Leprol. 2005 Jul-Aug;71(4):288-9. doi: 10.4103/0378-6323.16628.

DOI:10.4103/0378-6323.16628
PMID:16394445
Abstract
摘要

相似文献

1
Imatinib induced Stevens-Johnson syndrome: lack of recurrence following re-challenge with a lower dose.
Indian J Dermatol Venereol Leprol. 2005 Jul-Aug;71(4):288-9. doi: 10.4103/0378-6323.16628.
2
Sti571-induced Stevens-Johnson Syndrome.
Br J Haematol. 2002 Oct;119(1):274-5. doi: 10.1046/j.1365-2141.2002.37133.x.
3
Imatinib-induced Stevens-Johnsons syndrome.伊马替尼诱发的史蒂文斯-约翰逊综合征。
BMJ Case Rep. 2013 Jan 23;2013:bcr2012007926. doi: 10.1136/bcr-2012-007926.
4
Imatinib-induced Stevens-Johnson syndrome: recurrence after re-challenge with a lower dose.伊马替尼诱导的史蒂文斯-约翰逊综合征：低剂量再次激发后复发
Ann Hematol. 2007 Jul;86(7):537-8. doi: 10.1007/s00277-007-0265-y. Epub 2007 Feb 8.
5
Stevens-Johnson syndrome after treatment with STI571: a case report.接受STI571治疗后发生史蒂文斯-约翰逊综合征：一例报告
Br J Haematol. 2002 Jun;117(3):620-2. doi: 10.1046/j.1365-2141.2002.03499.x.
6
Imatinib mesylate induced immune thrombocytopenia.
Leuk Lymphoma. 2007 Nov;48(11):2261-3. doi: 10.1080/10428190701615934.
7
Imatinib mesylate: a new pill for chronic myelogenous leukemia.
Cancer Pract. 2001 Sep-Oct;9(5):263-5. doi: 10.1046/j.1523-5394.2001.95003.x.
8
Severe tumor lysis syndrome during treatment with STI 571 in a patient with chronic myelogenous leukemia accelerated phase.一名慢性粒细胞白血病加速期患者在接受STI 571治疗期间发生严重肿瘤溶解综合征。
Ann Oncol. 2002 Nov;13(11):1833-4. doi: 10.1093/annonc/mdf304.
9
Pigmentary changes in chronic myeloid leukemia patients treated with imatinib mesylate.接受甲磺酸伊马替尼治疗的慢性髓性白血病患者的色素沉着变化。
Ann Oncol. 2004 Feb;15(2):358-9. doi: 10.1093/annonc/mdh068.
10
Photosensitization in chronic myelogenous leukaemia patients treated with imatinib mesylate.甲磺酸伊马替尼治疗的慢性粒细胞白血病患者的光敏反应
Br J Haematol. 2003 Mar;120(6):1091-2. doi: 10.1046/j.1365-2141.2003.04208_3.x.

引用本文的文献

1
Emerging Insights into Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Induced by Immune Checkpoint Inhibitor and Tumor-Targeted Therapy.免疫检查点抑制剂和肿瘤靶向治疗诱导的史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的新见解
J Inflamm Res. 2024 Apr 17;17:2337-2351. doi: 10.2147/JIR.S454673. eCollection 2024.
2
Evaluation of Delayed-Type Hypersensitivity to Antineoplastic Drugs-An Overview.抗肿瘤药物迟发型超敏反应的评估——综述
Cancers (Basel). 2023 Feb 14;15(4):1208. doi: 10.3390/cancers15041208.
3
Potentially life‑threatening severe cutaneous adverse reactions associated with tyrosine kinase inhibitors (Review).
与酪氨酸激酶抑制剂相关的潜在危及生命的严重皮肤不良反应（综述）。
Oncol Rep. 2021 Mar;45(3):891-898. doi: 10.3892/or.2020.7911. Epub 2020 Dec 24.
4
Severe cutaneous adverse reactions induced by targeted anticancer therapies and immunotherapies.靶向抗癌疗法和免疫疗法引起的严重皮肤不良反应。
Cancer Manag Res. 2018 May 17;10:1259-1273. doi: 10.2147/CMAR.S163391. eCollection 2018.
5
Anticancer Drugs Induced Severe Adverse Cutaneous Drug Reactions: An Updated Review on the Risks Associated with Anticancer Targeted Therapy or Immunotherapies.抗癌药物引起的严重皮肤不良反应：抗癌靶向治疗或免疫治疗相关风险的最新综述。
J Immunol Res. 2018 Jan 17;2018:5376476. doi: 10.1155/2018/5376476. eCollection 2018.
6
A rare case of imatinib-induced erythroderma.一例罕见的伊马替尼诱发的红皮病。
Indian J Pharmacol. 2013 Nov-Dec;45(6):634-5. doi: 10.4103/0253-7613.121386.
7
Life-threatening dermatologic adverse events in oncology.肿瘤学中危及生命的皮肤不良反应。
Anticancer Drugs. 2014 Feb;25(2):225-34. doi: 10.1097/CAD.0000000000000032.
8
Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec, Gleevectrade mark).治疗慢性髓性白血病的选择：聚焦伊马替尼（格列卫，商品名）。
Ther Clin Risk Manag. 2008 Feb;4(1):163-87.